CASE DISCUSSION

Therapeutic options for MRSA

Presented from India by Dr. Rishabh Kumar Mittal

Likes

3338

Views

134

Bookmarks

Case Description

Methicillin-resistant Staphylococcus aureus (MRSA) infections present significant therapeutic challenges due to their resistance to commonly used antibiotics. Effective treatment options include the use of antibiotics such as vancomycin, daptomycin, and linezolid, which are specifically targeted...

Case Summary

MRSA (Methicillin-resistant Staphylococcus aureus) is a prominent organism in Western countries, while its prevalence is lower in India and Southeast Asia. Despite this, drugs used for empirical MRSA coverage are often overused in intensive care settings. Understanding the appropriate use of various therapeutic options is crucial for clinicians.

Speaker Profile

Dr. Rishabh Kumar Mittal

Alumni- Fortis Escorts Heart Institute

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.